Annelies Van Hemelryk

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Radical Prostatectomy

Cell Cycle Arrest

Optical Coherence Tomography

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, Debra Stuurman, Sigrun Erkens-Schulze, Sem Van 't Geloof, Wilma J Teubel, Stijn L W Koolen, Elena S Martens-Uzunova, Martin E van Royen, Ronald de Wit, Ron H J Mathijssen, Thomas A Kirkland
Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition. Molecular cancer therapeutics (2023)
Annelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, Corrina M A de Ridder, Debra C Stuurman, Guido W Jenster, Martin E van Royen, Thomas A Kirkland
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. Cells 12 (10) (2023)
Annelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, Debra C Stuurman, Wilma J Teubel, Sigrun Erkens-Schulze, Esther I Verhoef, Sebastiaan Remmers, Amrish J Mahes, G J L H Geert van Leenders, Martin E van Royen, Harmen J G van de Werken, Magda Grudniewska, Guido W Jenster, Thomas A Kirkland
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling. Cells 11 (22) (2022)
Annelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, Pim J French, Thomas A Kirkland, Martin E van Royen
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing. Biomolecules 11 (11) (2021)